Nyxoah SA

NYXH Nasdaq CIK: 0001857190

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type other
SEC Category Accelerated filerEmerging growth company
State of Incorporation Belgium
Country Belgium
Business Address RUE EDOUARD BELIN 12, MONT-SAINT-GUIBERT, , 1435
Mailing Address RUE EDOUARD BELIN 12, MONT-SAINT-GUIBERT, , 1435
Phone 3210222355
Fiscal Year End 1231
EIN 000000000

Recent SEC Filings

Form Type Date Filed Document
20-F Foreign company annual report March 26, 2026 View on SEC
6-K Foreign company current report March 19, 2026 View on SEC
6-K Foreign company current report January 30, 2026 View on SEC
6-K Foreign company current report January 14, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) December 29, 2025 View on SEC
6-K Foreign company current report December 19, 2025 View on SEC
6-K Foreign company current report December 5, 2025 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment November 24, 2025 View on SEC
424B5 Prospectus supplement November 17, 2025 View on SEC
6-K Foreign company current report November 14, 2025 View on SEC

Annual Reports

20-F March 26, 2026
  • Developing the Genio® system, a battery-free, implantable neurostimulation device for Obstructive Sleep Apnea.
  • Expanding commercial footprint with presence in over 100 clinical centers across Europe and Australia.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.